Pacific Biosciences Of California reported $-53.19M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Agilent USD 444M 45M Jun/2026
Bruker USD 83.5M 13.9M Sep/2026
Danaher USD 1.25B 118M Sep/2026
General Electric Aerospace USD 2.22B 123M Sep/2026
Illumina USD 305M 45M Sep/2026
Myriad Genetics USD -3M 20.3M Dec/2025
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Quidel USD 12.1M 27.4M Sep/2026
Revvity USD 124.63M 1.51M Sep/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Standard Biotools USD -7.83M 1.59M Jun/2026
Thermo Fisher Scientific USD 2.46B 277M Sep/2026
Waters USD 10M 138M Jun/2026